The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis

被引:131
作者
Wittkowski, A
Richards, HL
Griffiths, CEM
Main, CJ
机构
[1] Univ Manchester, Wythenshawe Hosp, Sch Psychiat & Behav Sci, Acad Div Clin Psychol, Manchester M23 9LT, Lancs, England
[2] Salford Royal Hosp NHS Trust, Hope Hosp, Dept Behav Med, Manchester, Lancs, England
[3] Univ Manchester, Salford Royal Hosp NHS Trust, Sch Med,Hope Hosp, Dermatol Ctr, Manchester, Lancs, England
关键词
quality of life; atopic dermatitis; stigmatisation;
D O I
10.1016/S0022-3999(03)00572-5
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The aim of the study was to assess the influence of general and dermatitis-specific psychological and clinical factors on quality of life in adults with atopic dermatitis (AD). Method: A total of 125 adults recruited through the National Eczema Society of U.K. (NES) completed a number of psychological and dermatological questionnaires, including the Dermatology Life Quality Index (DLQI), the Stigmatisation and Eczema Questionnaire (SEQ), the Hospital Anxiety and Depression Scale (HADS), the Fear of Negative Evaluation Scale (FNE) and the Rosenberg Self-Esteem Scale (RSE). Results: Pearson's correlational analyses suggested that perceptions of stigma were significantly associated with psychological factors as well as quality of life (Ps<.01). An association was also found between perceived stigma and disease severity (-.28, P<.01). Almost 46% of participants were identified as having probable mood disorder. Regression analysis indicated that perceptions of stigma and depression accounted for 44.5% of the variance in quality of life in this sample [F(3,121)=34.18, P<.001], when disease severity was controlled for. Conclusion: Psychological factors and disease severity were strong predictors of quality of life in adults with AD. AD-related perceptions of stigma were of particular importance in predicting AD-related quality of life over and above more general psychological factors, such as depression. These findings have important implications for the psychological and clinical management of AD. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:195 / 200
页数:6
相关论文
共 47 条
[1]   Development and validation of a quality of life instrument for cutaneous diseases [J].
Anderson, RT ;
Rajagopalan, R .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (01) :41-50
[2]  
[Anonymous], ACTA DERM VENERE S92, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]
[3]  
Badia X, 1999, BRIT J DERMATOL, V141, P698
[4]   TREATMENT OF ATOPIC-DERMATITIS - A COMPARISON OF PSYCHOLOGICAL AND DERMATOLOGICAL APPROACHES TO RELAPSE PREVENTION [J].
EHLERS, A ;
STRANGIER, U ;
GIELER, U .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1995, 63 (04) :624-635
[5]  
EUN H C, 1990, Annals of Dermatology, V2, P9
[6]   The self-administered psoriasis area and severity index is valid and reliable [J].
Feldman, SR ;
Fleischer, AB ;
Reboussin, DM ;
Rapp, SR ;
Exum, ML ;
Clark, AR ;
Nurre, L .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (01) :183-186
[7]   DERMATOLOGY LIFE QUALITY INDEX (DLQI) - A SIMPLE PRACTICAL MEASURE FOR ROUTINE CLINICAL USE [J].
FINLAY, AY ;
KHAN, GK .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1994, 19 (03) :210-216
[8]   Measurement of disease activity and outcome in atopic dermatitis [J].
Finlay, AY .
BRITISH JOURNAL OF DERMATOLOGY, 1996, 135 (04) :509-515
[9]   PATIENT MEASUREMENT OF PSORIASIS DISEASE SEVERITY WITH A STRUCTURED INSTRUMENT [J].
FLEISCHER, AB ;
RAPP, SR ;
REBOUSSIN, DM ;
VANARTHOS, JC ;
FELDMAN, SR .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (06) :967-969
[10]   ANXIETY AND ATOPIC-DERMATITIS [J].
GARRIE, EV ;
GARRIE, SA ;
MOTE, T .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1974, 42 (05) :742-742